Cart
sales@molnova.com
Buspirone
CAS No. 36505-84-7
Buspirone ( Buspirone free base; Ansial )
Catalog No. M27358 CAS No. 36505-84-7
Buspirone free base is an agonist of serotonin receptor with anxiolytic activity. Buspirone free base has an efficacy comparable to diazepam.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 393 | Get Quote |
|
| 10MG | 581 | Get Quote |
|
| 25MG | 888 | Get Quote |
|
| 50MG | 1242 | Get Quote |
|
| 100MG | 1674 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBuspirone
-
NoteResearch use only, not for human use.
-
Brief DescriptionBuspirone free base is an agonist of serotonin receptor with anxiolytic activity. Buspirone free base has an efficacy comparable to diazepam.
-
DescriptionBuspirone free base is an agonist of serotonin receptor with anxiolytic activity. Buspirone free base has an efficacy comparable to diazepam.
-
SynonymsBuspirone free base; Ansial
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
RecptorEGFR (T790M);EGFR (L858R/T790M);EGFR (del19/T790M)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number36505-84-7
-
Formula Weight385.5
-
Molecular FormulaC21H31N5O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sullivan I, et al. Next-Generation EGFR Tyrosine Kinase Inhibitors for Treating EGFR-Mutant Lung Cancer beyond First Line. Front Med (Lausanne). 2017 Jan 18;3:76.
molnova catalog
related products
-
PHCCC
PHCCC is a Group I metabotropic glutamate receptor antagonist and a positive allosteric modulator of mGluR4. It also is a potent to antagonism for mGluR2 and mGluR8.
-
Vabicaserin hydrochl...
Vabicaserin hydrochloride is a selective agonist of 5-hydroxytryptamine 2C (5-HT2C) receptor (EC50: 8 nM).
-
EMD-281014
EMD-281014 (Pruvanserin, LSN2411347, LY-2422347) is a potent, highly selective 5-HT2A antagonist with Ki of 0.87 nM.
